Corundum Neuroscience Overview
Corundum Neuroscience is a venture builder and fund advancing transformative neuroscience solutions from lab-to-life. The CNS team combines deep domain expertise with a track-record of venture-building success to accelerate neuroscience solutions across the entire innovation lifecycle. Taking a long-term investment approach, Corundum Neuroscience helps researchers, entrepreneurs and startups develop life-changing solutions that target specific disease areas and outcomes to enhance people's health, longevity and happiness. Corundum Neuroscience operates under parent company Corundum Innovation, a Japanese-based investment firm providing comprehensive support through research funding, venture investment services and new business consulting.
Latest News
growth-positive
Offline Studio Partners with Corundum Neuroscience and Corundum Systems Biology for New Life Sciences Venture Creation
Corundum Neuroscience (CNS) and Corundum Systems Biology (CSB) have partnered with Offline Studio to launch a new venture creation initiative. This initiative aims to leverage data from the Human Phenotype Project to develop life sciences products that enhance human wellbeing. Both CNS and CSB, alongside Offline Studio, will initially commit $1 million each, with an additional $1.5 million reserved for later stages. The initiative will focus on using AI to derive insights from health data, with Offline Studio leading the venture creation process. This collaboration is expected to bring impactful health solutions to market, with a structured process for project identification, validation, and company formation.
PartnersInvestment
growth-positive
/PRNewswire/ -- Corundum Neuroscience, a leading neuroscience venture builder and fund, today announced it has awarded a research grant for a project led by...
Corundum Neuroscience has awarded a research grant for a project led by Professor Asya Rolls at Tel Aviv University. The project aims to map brain areas suitable for neuromodulation to develop therapies for autoimmune and inflammatory diseases. The study will use viral tracing techniques to explore brain regions roles in immune regulation and identify potential therapeutic targets. The research could lead to novel non-invasive treatments for conditions like Crohns disease and multiple sclerosis. Corundum Neuroscience, a venture builder in neuroscience, supports this initiative through Ramot, Tel Aviv Universitys tech transfer company.
Partners
growth-positive
/PRNewswire/ -- Corundum Neuroscience (CNS), the neuroscience venture builder and fund, and Corundum Systems Biology (CSB), a leading investor in life-changing...
Corundum Neuroscience and Corundum Systems Biology are hosting panel sessions at the inaugural SXSW London in June 2025. The discussions will focus on the role of sleep innovation for brain health and the influence of the microbiome on human well-being. The panels will explore how microbiome science is reshaping drug development and personalized health interventions, as well as how sleep technology is unlocking human potential by enhancing cognitive health and enabling early detection of neurodegenerative diseases. These sessions highlight the companies commitment to advancing transformative neuroscience and systems biology solutions.
Growth-Positive
Joy Ventures Rebrands as Corundum Neuroscience, Launching New Venture Builder and Fund to Spur Neuroscience Technology Innovation
Corundum Neuroscience, formerly Joy Ventures, has launched a new neuroscience-focused venture builder and fund to spur neuroscience research and innovation. The company works with researchers and entrepreneurs to build and grow companies developing innovative solutions in various health and disease areas. The companys lab-to-life model supports the entire innovation journey, from research and concept to commercialization. The rebranding signifies the companys focus on facilitating greater neuroscience research and innovation. Corundum Neuroscience operates under parent company Corundum Innovation, a Japanese-based investment firm.
InvestmentRebrandingExpand
growth-positive
Goodbye cybersecurity, hello CalmTech: How Israeli tech is transforming mental wellness
The article discusses the growing importance of mental wellbeing and the role of tech startups in this space. It highlights the increasing consumer demand for stress-relief and wellness solutions, and the subsequent rise in institutional investment in mental wellbeing tech. The article mentions several startups that are developing innovative solutions in this space, including Reflect Innovation, Wisdo, and Myndlift. It also discusses the shift in the healthcare market towards preventative care and the rise of employee wellbeing. The article is written by Miri Polachek, CEO of Joy Ventures, a fund dedicated to building, funding, and supporting consumer wellbeing startups.
InvestmentCustomersPartners
Team Members
6
Web & Social Links
| Website | cnsfund.com |
Locations
Ha-Menofim Street 11, Herzliya, Israel
Photos & Videos
No files yet
Corundum Neuroscience Business
Business models
—
Product stage
—
Employees
—
Sector
—Target Customer
—Core Technology
—Tags (13)
neurologylife-sciencesbiomedsleep-disordershealthcareneurosciencedigital-healthcarewellnessconsumerswearablemental-healthbiomarkerschronic-painCorundum Neuroscience Financials
—
Total funding
—
Capital raised
—
Last funding
—
Funding stage
—
Total rounds
—
Investors
Corundum Neuroscience Lifecycle
Corundum Neuroscience News
13 articles
growth-positive
Offline Studio Partners with Corundum Neuroscience and Corundum Systems Biology for New Life Sciences Venture Creation
Corundum Neuroscience (CNS) and Corundum Systems Biology (CSB) have partnered with Offline Studio to launch a new venture creation initiative. This initiative aims to leverage data from the Human Phenotype Project to develop life sciences products that enhance human wellbeing. Both CNS and CSB, alongside Offline Studio, will initially commit $1 million each, with an additional $1.5 million reserved for later stages. The initiative will focus on using AI to derive insights from health data, with Offline Studio leading the venture creation process. This collaboration is expected to bring impactful health solutions to market, with a structured process for project identification, validation, and company formation.
PartnersInvestment
growth-positive
/PRNewswire/ -- Corundum Neuroscience, a leading neuroscience venture builder and fund, today announced it has awarded a research grant for a project led by...
Corundum Neuroscience has awarded a research grant for a project led by Professor Asya Rolls at Tel Aviv University. The project aims to map brain areas suitable for neuromodulation to develop therapies for autoimmune and inflammatory diseases. The study will use viral tracing techniques to explore brain regions roles in immune regulation and identify potential therapeutic targets. The research could lead to novel non-invasive treatments for conditions like Crohns disease and multiple sclerosis. Corundum Neuroscience, a venture builder in neuroscience, supports this initiative through Ramot, Tel Aviv Universitys tech transfer company.
Partners
growth-positive
/PRNewswire/ -- Corundum Neuroscience (CNS), the neuroscience venture builder and fund, and Corundum Systems Biology (CSB), a leading investor in life-changing...
Corundum Neuroscience and Corundum Systems Biology are hosting panel sessions at the inaugural SXSW London in June 2025. The discussions will focus on the role of sleep innovation for brain health and the influence of the microbiome on human well-being. The panels will explore how microbiome science is reshaping drug development and personalized health interventions, as well as how sleep technology is unlocking human potential by enhancing cognitive health and enabling early detection of neurodegenerative diseases. These sessions highlight the companies commitment to advancing transformative neuroscience and systems biology solutions.
Growth-Positive
Joy Ventures Rebrands as Corundum Neuroscience, Launching New Venture Builder and Fund to Spur Neuroscience Technology Innovation
Corundum Neuroscience, formerly Joy Ventures, has launched a new neuroscience-focused venture builder and fund to spur neuroscience research and innovation. The company works with researchers and entrepreneurs to build and grow companies developing innovative solutions in various health and disease areas. The companys lab-to-life model supports the entire innovation journey, from research and concept to commercialization. The rebranding signifies the companys focus on facilitating greater neuroscience research and innovation. Corundum Neuroscience operates under parent company Corundum Innovation, a Japanese-based investment firm.
InvestmentRebrandingExpand
growth-positive
Goodbye cybersecurity, hello CalmTech: How Israeli tech is transforming mental wellness
The article discusses the growing importance of mental wellbeing and the role of tech startups in this space. It highlights the increasing consumer demand for stress-relief and wellness solutions, and the subsequent rise in institutional investment in mental wellbeing tech. The article mentions several startups that are developing innovative solutions in this space, including Reflect Innovation, Wisdo, and Myndlift. It also discusses the shift in the healthcare market towards preventative care and the rise of employee wellbeing. The article is written by Miri Polachek, CEO of Joy Ventures, a fund dedicated to building, funding, and supporting consumer wellbeing startups.
InvestmentCustomersPartners
growth-positive
Technologies that can help us stay calm during Covid-19
Joy Ventures, an Israeli venture capital firm and tech startup studio, is focusing on funding and developing consumer products for emotional well-being. The company was founded in 2017 by Corundum Open Innovation, a Japanese VC that invests in Israeli tech companies. The goal is to develop wearables and apps that lower stress and enhance mood without pharmaceuticals. Joy Ventures has already funded 36 research projects and five companies, including Empathic Technologies, Reflect Innovation, Vi Trainer, NYX Technologies, and Sanga.
InvestmentExpand
growth-positive
Commentary: 5 companies that want to track your emotions
The article discusses the rise of emotion-sensing technologies as a response to the increasing mental health issues during the COVID-19 pandemic. It highlights five companies - Healium, Reflect Innovation, Inner Balance, Sonde Health, and Feel - that are at the forefront of this innovation. These companies use various technologies, including augmented and virtual reality, wearable technology, biofeedback, and cognitive behavioral therapy, to help individuals monitor and regulate their emotions. The market for emotion detection technologies is projected to grow from $21.6 billion in 2019 to $56 billion by 2024.
CustomersPartners
We're feeling more lonely than ever-here are 5 ways technology can help
growth-positive
3 Big Well-Being Trends in the Wake of the COVID-19 Pandemic
The article discusses the impact of COVID-19 on the wellness sector, highlighting the launch of the Thrive Reset Zapp, a joint project of Thrive Global and Zoom. This product is designed to help users de-stress before, during, and after Zoom meetings. The global wellness economy, currently valued at $4.5 trillion, is expected to play a major role in the post-pandemic future.
Partners
growth-positive
Covid-19 got you down? Joy Ventures is determined to innovate our behavioral health
Joy Ventures, an Israel-based startup studio, is working to provide wellness and behavioral health solutions to help people cope with the effects of isolation and social distancing due to the Covid-19 pandemic. The company, which acts as a venture capital firm, incubator, and academic collaborator, was founded by the Israeli-Japanese Corundum Open Innovation Fund. It supports organizations that are actively working on wellness solutions. Joy Ventures has five companies in its portfolio since its founding in 2017, when it earmarked $50 million for the first stage of its operations and investment.
InvestmentExpand
growth-positive
Joy Ventures Startup Studio Launches EIR Program - FinSMEs
Joy Ventures, a startup studio based in Tel Aviv, Israel, has launched its Entrepreneur-in-Residence (EIR) platform. The platform is designed to establish new startups in the emotional wellbeing category. It will serve as the cornerstone of Joy Ventures’ venture design efforts, extending the company’s existing product ideation programs, and operating in parallel to its continued investment activity in early to growth stage startups. The EIR platform will be led by Ron Gabay, Joy Ventures’ Head of Innovation & Venture Design.
InvestmentExpand
Israel-Japan VC fund invests in bringing joy to our stressful lives
growth-positive
$50m Israeli fund to invest in neuro wellness
JOY Ventures, a new investment firm, has recently inaugurated its office in Herzliya Pituach, and earmarked $50 million for the first stages of its operations. The firm will focus on startup companies, technological incubators for entrepreneurs and grants for academic research in the emerging field of Neuro Wellness. The company will bring together global researchers from a range of fields with Israeli entrepreneurs to promote new developments. The technological incubator, which is located in Herzliyah, will foster technological anti stress solutions that impact neuro wellness.
InvestmentExpand
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
Corundum Neuroscience Internal
Recent Updates
Ortal Wein
· ortalw@sncentral.org · Manual · 2023-11-16 14:35:52.000000
Sabrina Kestenbaum
· sabrina@joyventures.com · Manual · 2023-11-28 10:18:58.000000
Ortal Wein
· ortalw@sncentral.org · Manual · 2023-11-16 14:25:53.000000
Ortal Wein
· ortalw@sncentral.org · Manual · 2022-09-20 08:54:16.000000
Sabrina Kestenbaum
· sabrina@joyventures.com · Manual · 2023-11-21 12:30:23.000000
Ortal Wein
· ortalw@sncentral.org · Manual · 2022-09-20 08:45:46.000000
Ortal Wein
· ortalw@sncentral.org · Manual · 2023-11-16 14:32:52.000000
Ortal Wein
· ortalw@sncentral.org · Manual · 2022-09-20 08:36:23.000000
Ortal Wein
· ortalw@sncentral.org · Manual · 2023-11-16 14:35:49.000000
Ortal Wein
· ortalw@sncentral.org · Automatic · 2025-10-28 07:00:53.000000
Ortal Wein
· ortalw@sncentral.org · Manual · 2023-11-16 14:35:52.000000
Ortal Wein
· ortalw@sncentral.org · Manual · 2022-09-20 08:25:25.000000
Ortal Wein
· ortalw@sncentral.org · Manual · 2022-09-20 08:24:46.000000
Ortal Wein
· ortalw@sncentral.org · Manual · 2023-11-16 14:35:50.000000
Ortal Wein
· ortalw@sncentral.org · Manual · 2022-09-20 08:25:06.000000
Sabrina Kestenbaum
· sabrina@joyventures.com · Manual · 2023-11-21 12:30:23.000000
Ortal Wein
· ortalw@sncentral.org · Manual · 2022-09-20 08:48:00.000000
Sabrina Kestenbaum
· sabrina@joyventures.com · Manual · 2023-11-21 12:30:25.000000
Ortal Wein
· ortalw@sncentral.org · Manual · 2022-09-20 08:46:18.000000
Ortal Wein
· ortalw@sncentral.org · Manual · 2023-11-16 14:35:51.000000
Ortal Wein
· ortalw@sncentral.org · Manual · 2022-09-20 08:54:31.000000
Ortal Wein
· ortalw@sncentral.org · Manual · 2023-11-16 14:35:52.000000
Sabrina Kestenbaum
· sabrina@joyventures.com · Manual · 2023-11-28 10:19:03.000000
Ortal Wein
· ortalw@sncentral.org · Manual · 2022-09-20 09:04:22.000000
Ortal Wein
· ortalw@sncentral.org · Manual · 2023-11-16 14:35:50.000000
Ortal Wein
· ortalw@sncentral.org · Manual · 2022-09-20 08:46:52.000000
Ortal Wein
· ortalw@sncentral.org · Manual · 2023-11-16 14:35:52.000000
Ortal Wein
· ortalw@sncentral.org · Manual · 2023-11-16 14:35:53.000000
Ortal Wein
· ortalw@sncentral.org · Manual · 2022-09-20 08:24:46.000000
Sabrina Kestenbaum
· sabrina@joyventures.com · Manual · 2023-11-21 12:30:26.000000
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 57/100 |
| Missing | funding stage, product stage, sector, number of employees, business model, tag line, video or image, funding rounds, markets |
| BI Verification | Jenny Sotnik-Talisman |
| Registrar ID | 515480960 |
| Crunchbase | joy-ventures |
| Phone | +972722500610 |
| Creator | Ben Yaron |
| Creator email | benyaron@gmail.com |
| Last updater | Ortal Wein |
| Updater email | ortalw@sncentral.org |
| Last update | 2023-11-16T00:00:00.000Z |
| Created | 2017-02-08T00:00:00.000Z |
| Status detail | Active |